Murat Emre, M.D. - Publications

Affiliations: 
Neurology Istanbul University, İstanbul, Turkey 
Area:
Alzheimer's Disease

128 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kuipers DJS, Tufekcioglu Z, Bilgiç B, Olgiati S, Dremmen MHG, van IJcken WFJ, Breedveld GJ, Mancini GMS, Hanagasi HA, Emre M, Bonifati V. Late-onset phenotype associated with a homozygous GJC2 missense mutation in a Turkish family. Parkinsonism & Related Disorders. PMID 31431325 DOI: 10.1016/j.parkreldis.2019.07.033  0.48
2019 Dursun E, Alaylıoğlu M, Bilgiç B, Hanağası H, Gürvit H, Emre M, Gezen-Ak D. Amyloid Beta Adsorption Problem with Transfer Plates in Amyloid Beta 1-42 IVD Kits. Journal of Molecular Neuroscience : Mn. PMID 30635782 DOI: 10.1007/s12031-019-1261-0  0.32
2018 Guven G, Bilgic B, Tufekcioglu Z, Erginel Unaltuna N, Hanagasi H, Gurvit H, Singleton A, Hardy J, Emre M, Gulec C, Bras J, Guerreiro R, Lohmann E. Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia. Journal of Alzheimer's Disease : Jad. PMID 30475763 DOI: 10.3233/JAD-180599  0.88
2017 Uysal-Cantürk P, Hanağasi HA, Bilgiç B, Gürvit H, Emre M. An assessment of Movement Disorder Society Task Force Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease. European Journal of Neurology. PMID 28941002 DOI: 10.1111/ene.13467  0.32
2017 Olgiati S, Doğu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Sürmeli R, Sünter G, Doğan T, Yalçın AD, ... ... Emre M, et al. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism & Related Disorders. PMID 28347615 DOI: 10.1016/j.parkreldis.2017.03.012  0.48
2017 Hanagasi HA, Tufekcioglu Z, Emre M. Dementia in Parkinson's disease. Journal of the Neurological Sciences. PMID 28088312 DOI: 10.1016/j.jns.2017.01.012  0.48
2016 Senturk G, Bilgic B, Arslan AB, Bayram A, Hanagasi H, Gurvit H, Emre M. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease. International Psychogeriatrics. 1-10. PMID 27780496 DOI: 10.1017/S1041610216001812  0.88
2016 Guven G, Lohmann E, Bras J, Gibbs JR, Gurvit H, Bilgic B, Hanagasi H, Rizzu P, Heutink P, Emre M, Erginel-Unaltuna N, Just W, Hardy J, Singleton A, Guerreiro R. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients. Plos One. 11: e0162592. PMID 27632209 DOI: 10.1371/journal.pone.0162592  0.88
2016 Alaylıoğlu M, Gezen-Ak D, Dursun E, Bilgiç B, Hanağası H, Ertan T, Gürvit H, Emre M, Eker E, Uysal Ö, Yılmazer S. The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort. Journal of Geriatric Psychiatry and Neurology. PMID 27076484 DOI: 10.1177/0891988716640373  0.32
2016 Hanagasi HA, Giri A, Guven G, Bilgiç B, Hauser AK, Emre M, Heutink P, Basak N, Gasser T, Simón-Sánchez J, Lohmann E. A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family. Parkinsonism & Related Disorders. PMID 26972524 DOI: 10.1016/j.parkreldis.2016.03.001  0.48
2016 Tufekcioglu Z, Cakar A, Bilgic B, Hanagasi H, Gurvit H, Emre M. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism. Neurocase. 1-3. PMID 26962957 DOI: 10.1080/13554794.2016.1142567  0.88
2015 Lohmann E, Coquel AS, Honoré A, Gurvit H, Hanagasi H, Emre M, Leutenegger AL, Drouet V, Sahbatou M, Guven G, Erginel-Unaltuna N, Deleuze JF, Lesage S, Brice A. A new F-box protein 7 gene mutation causing typical Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1130-3. PMID 26010069 DOI: 10.1002/mds.26266  0.88
2015 Hanagasi HA, Bilgiç B, Abbink TE, Hanagasi F, Tüfekçioğlu Z, Gürvit H, Başak N, van der Knaap MS, Emre M. Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation. Parkinsonism & Related Disorders. 21: 544-6. PMID 25745790 DOI: 10.1016/j.parkreldis.2015.02.013  0.88
2015 Gür Özmen S, Hanağasi H, Gürvit H, Emre M, Akman Demir G. Neuro-Behçet’s disease with Chorea Noropsikiyatri Arsivi. 52: 200-201. DOI: 10.5152/npa.2015.7316  0.88
2014 Emre M, Ford PJ, Bilgiç B, Uç EY. Cognitive impairment and dementia in Parkinson's disease: practical issues and management. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 663-72. PMID 24757114 DOI: 10.1002/mds.25870  0.88
2014 Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C. Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study. Clinical Neuropharmacology. 37: 9-16. PMID 24434526 DOI: 10.1097/WNF.0000000000000010  0.88
2014 Gür Özmen S, Gürvit H, Hanaǧasi HA, Alpsan Gökmen MH, Emre M. Supranuclear gaze abnormality in sporadic-creutzfeldt jacob disease | Sporadik creutzfeldt-jacob hastali{dotless}ǧi{dotless}nda supranükleer baki{dotless}ş parezisi Noropsikiyatri Arsivi. 51: 91-92. DOI: 10.4274/npa.y7341  0.88
2013 Bilgiç B, Bayram A, Hanağasi HA, Tümaç A, Uysal P, Şentürk G, Alpsan H, Lohmann E, Gürvit H, Emre M. The Relationship of White Matter Hyperintensities with Depressive Symptoms and Daily Living Activities in Early-Stage Alzheimer's Disease Patients. Noro Psikiyatri Arsivi. 50: 360-363. PMID 28360570 DOI: 10.4274/Npa.y6603  0.32
2013 Hanagasi HA, Bilgiç B, Emre M. Neuroimaging, biomarkers, and management of dementia with lewy bodies. Frontiers in Neurology. 4: 151. PMID 24109473 DOI: 10.3389/fneur.2013.00151  0.88
2013 Guerreiro R, Bilgic B, Guven G, Brás J, Rohrer J, Lohmann E, Hanagasi H, Gurvit H, Emre M. Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family. Neurobiology of Aging. 34: 2890.e1-5. PMID 23870839 DOI: 10.1016/j.neurobiolaging.2013.06.005  0.88
2013 Rana AQ, Khondker S, Kabir A, Owalia A, Khondker S, Emre M. Impact of cognitive dysfunction on drooling in Parkinson's disease. European Neurology. 70: 42-5. PMID 23711510 DOI: 10.1159/000348571  0.88
2013 Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1064-71. PMID 23630119 DOI: 10.1002/mds.25364  0.88
2013 Guerreiro RJ, Lohmann E, Brás JM, Gibbs JR, Rohrer JD, Gurunlian N, Dursun B, Bilgic B, Hanagasi H, Gurvit H, Emre M, Singleton A, Hardy J. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. Jama Neurology. 70: 78-84. PMID 23318515 DOI: 10.1001/jamaneurol.2013.579  0.88
2013 Bilgiç B, Bayram A, Hanaǧasi HA, Tümaç A, Uysal P, Şentürk G, Alpsan H, Lohmann E, Gürvit H, Emre M. The relationship of white matter hyperintensities with depressive symptoms and daily living activities in early-stage Alzheimer's disease patients | Erken evre alzheimer hastali{dotless}ǧi{dotless}nda i̇zlenen ak madde hiperintensitelerinin depresif semptomlar ve günlük yaşam aktiviteleri ile i̇lişkisi Noropsikiyatri Arsivi. 50: 360-363. DOI: 10.4274/Npa.y6603  0.88
2013 Üresin Y, Ilbars H, Gürvit IH, Emre M. Experience in Alzheimer's Disease Clinical Trials in Turkey Global Clinical Trials For Alzheimer's Disease: Design, Implementation, and Standardization. 277-288. DOI: 10.1016/B978-0-12-411464-7.00017-1  0.88
2012 Gezen-Ak D, Dursun E, Bilgiç B, HanaÄŸasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal O, Yilmazer S. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. The Tohoku Journal of Experimental Medicine. 228: 189-96. PMID 23076256 DOI: DN/JST.JSTAGE/tjem/228.189  0.88
2012 Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1230-8. PMID 22915447 DOI: 10.1002/mds.25098  0.88
2012 Bilgic B, Hanagasi HA, Emre M. Dementia and behavioral neurology: recent advances. Journal of Neurology. 259: 1006-10. PMID 22527221 DOI: 10.1007/s00415-012-6460-3  0.88
2012 Lohmann E, Guerreiro RJ, Erginel-Unaltuna N, Gurunlian N, Bilgic B, Gurvit H, Hanagasi HA, Luu N, Emre M, Singleton A. Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiology of Aging. 33: 1850.e17-27. PMID 22503161 DOI: 10.1016/j.neurobiolaging.2012.02.020  0.88
2012 Bilgic B, Bayram A, Arslan AB, Hanagasi H, Dursun B, Gurvit H, Emre M, Lohmann E. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method. Parkinsonism & Related Disorders. 18: 562-6. PMID 22445249 DOI: 10.1016/j.parkreldis.2012.02.017  0.88
2012 Reichmann H, Emre M. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone. Expert Review of Neurotherapeutics. 12: 119-31. PMID 22288667 DOI: 10.1586/ern.11.203  0.88
2012 Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, ... Emre M, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 349-56. PMID 22275317 DOI: 10.1002/mds.24893  0.88
2012 Lohmann E, Dursun B, Lesage S, Hanagasi HA, Sevinc G, Honore A, Bilgic B, Gürvit H, Dogu O, Kaleagası H, Babacan G, Yazici J, Erginel-Unaltuna N, Brice A, Emre M. Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: 769-75. PMID 22233331 DOI: 10.1111/j.1468-1331.2011.03639.x  0.88
2012 Rascol O, Barone P, Behari M, Emre M, Giladi N, Olanow CW, Ruzicka E, Bibbiani F, Squillacote D, Patten A, Tolosa E. Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone. Clinical Neuropharmacology. 35: 15-20. PMID 22222634 DOI: 10.1097/WNF.0b013e318241520b  0.88
2012 Guerreiro RJ, Lohmann E, Kinsella E, Brás JM, Luu N, Gurunlian N, Dursun B, Bilgic B, Santana I, Hanagasi H, Gurvit H, Gibbs JR, Oliveira C, Emre M, Singleton A. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiology of Aging. 33: 1008.e17-23. PMID 22153900 DOI: 10.1016/j.neurobiolaging.2011.10.009  0.88
2012 Lohmann E, HanaÄŸası HA, Gürvit H, Kayacı G, Ruberg M, Yazıcı J, Emre M. The impact of familial structure on Parkinson's disease in Istanbul Medical School, Turkey. The International Journal of Neuroscience. 122: 102-5. PMID 21995451 DOI: 10.3109/00207454.2011.631715  0.88
2012 Demirtas-Tatlidede A, Gurvit H, Oktem-Tanor O, Emre M. Crossed aphasia in a dextral patient with logopenic/phonological variant of primary progressive aphasia. Alzheimer Disease and Associated Disorders. 26: 282-4. PMID 21959362 DOI: 10.1097/WAD.0b013e31823346c6  0.88
2011 Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D. Cognitive impairment in nondemented Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2483-95. PMID 22170275 DOI: 10.1002/mds.23919  0.88
2011 Hanagasi HA, Lohmann E, Dursun B, Honoré A, Lesage S, Dogu O, Kaleagasi H, Aydın O, Gürvit H, Erginel-Unaltuna N, Brice A, Emre M. LRRK2 mutations are uncommon in Turkey. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: e137. PMID 21914047 DOI: 10.1111/j.1468-1331.2011.03471.x  0.88
2011 Tufan F, Myftiu B, Aygun D, Keles N, Haroche J, Hanagasi H, Gurvit H, Emre M, Besisik S. Erdheim Chester disease presenting as slowly progressive cerebellar syndrome and asymptomatic widespread skeletal involvement. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: e93. PMID 21749566 DOI: 10.1111/j.1468-1331.2011.03378.x  0.88
2011 Hanagasi HA, Gurvit H, Unsalan P, Horozoglu H, Tuncer N, Feyzioglu A, Gunal DI, Yener GG, Cakmur R, Sahin HA, Emre M. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1851-8. PMID 21500280 DOI: 10.1002/mds.23738  0.88
2011 Poletti M, Emre M, Bonuccelli U. Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism & Related Disorders. 17: 579-86. PMID 21489852 DOI: 10.1016/j.parkreldis.2011.03.013  0.88
2011 Bronnick K, Emre M, Tekin S, Haugen SB, Aarsland D. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 824-9. PMID 21437985 DOI: 10.1002/mds.23525  0.88
2011 Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson's disease. Clinical Neurology and Neurosurgery. 113: 11-3. PMID 20800342 DOI: 10.1016/j.clineuro.2010.07.024  0.88
2010 Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, ... Emre M, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 75: 1062-9. PMID 20855849 DOI: 10.1212/WNL.0b013e3181f39d0e  0.88
2010 Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 9: 969-77. PMID 20729148 DOI: 10.1016/S1474-4422(10)70194-0  0.88
2010 Paisán-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1791-800. PMID 20669327 DOI: 10.1002/mds.23221  0.88
2010 Lindesay J, Bullock R, Daniels H, Emre M, Förstl H, Frölich L, Gabryelewicz T, Martínez-Lage P, Monsch AU, Tsolaki M, van Laar T. Turning principles into practice in Alzheimer's disease. International Journal of Clinical Practice. 64: 1198-209. PMID 20529136 DOI: 10.1111/j.1742-1241.2010.02417.x  0.88
2010 Eggert K, Squillacote D, Barone P, Dodel R, Katzenschlager R, Emre M, Lees AJ, Rascol O, Poewe W, Tolosa E, Trenkwalder C, Onofrj M, Stocchi F, Nappi G, Kostic V, et al. Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 896-905. PMID 20461807 DOI: 10.1002/mds.22974  0.88
2010 Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, et al. Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease. Cns Neuroscience & Therapeutics. 16: 246-53. PMID 20370805 DOI: 10.1111/j.1755-5949.2010.00141.x  0.88
2010 Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R. Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations. Journal of Alzheimer's Disease : Jad. 20: 301-11. PMID 20164585 DOI: 10.3233/JAD-2010-1362  0.88
2010 Tsolaki M, Papaliagkas V, Anogianakis G, Bernabei R, Emre M, Frolich L, Visser PJ, Michel JP, Pirttila T, Olde Rikkert M, Soininen H, Sobow T, Vellas B, Verhey F, Winblad B, et al. Consensus statement on dementia education and training in Europe. The Journal of Nutrition, Health & Aging. 14: 131-5. PMID 20126961  0.88
2010 Bilgiç B, Hanağası HA, Emre M. Parkinson’s disease dementia Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management. 177-191. DOI: 10.1017/CBO9781139856669.017  0.88
2009 Hanagasi HA, Serdaroglu P, Ozansoy M, Basak N, Tasli H, Emre M. Mitochondrial pathology in muscle of a patient with a novel parkin mutation. The International Journal of Neuroscience. 119: 1572-83. PMID 19922375 DOI: 10.1080/00207450903088019  0.88
2009 Vural P, DeÄŸirmencioÄŸlu S, Parildar-KarpuzoÄŸlu H, DoÄŸru-AbbasoÄŸlu S, Hanagasi HA, KaradaÄŸ B, Gürvit H, Emre M, Uysal M. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. Acta Neurologica Scandinavica. 120: 396-401. PMID 19744138 DOI: 10.1111/j.1600-0404.2009.01230.x  0.88
2009 Schapira AH, Emre M, Jenner P, Poewe W. Levodopa in the treatment of Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 982-9. PMID 19538218 DOI: 10.1111/j.1468-1331.2009.02697.x  0.88
2009 Emre M. Memantine: a new hope for treatment of Lewy body-related dementias? The Lancet. Neurology. 8: 594-5. PMID 19520612 DOI: 10.1016/S1474-4422(09)70144-9  0.88
2009 Dursun E, Gezen-Ak D, Ertan T, Bilgiç B, Gürvit H, Emre M, Eker E, Engin F, Uysal O, Yilmazer S. Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 27: 82-7. PMID 19155622 DOI: 10.1159/000193627  0.88
2009 Emre M. Classification and diagnosis of dementia: a mechanism-based approach. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 168-73. PMID 19146638 DOI: 10.1111/j.1468-1331.2008.02379.x  0.88
2009 Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ. Psychotic and compulsive symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 738-44. PMID 19133665 DOI: 10.1002/mds.22453  0.88
2009 Hauser RA, Panisset M, Abbruzzese G, Mancione L, Dronamraju N, Kakarieka A, Ahmed A, Albanese A, Bonuccelli U, Cakmur R, Chou K, Cloutier M, Cunha L, Desai H, Djaldetti R, ... ... Emre M, et al. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease Movement Disorders. 24: 541-550. PMID 19058133 DOI: 10.1002/mds.22343  0.88
2009 Lane R, He Y, Morris C, Leverenz JB, Emre M, Ballard C. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 392-400. PMID 19006190 DOI: 10.1002/mds.22357  0.88
2008 Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Annals of Neurology. 64: S81-92. PMID 19127578 DOI: 10.1002/ana.21455  0.88
2008 Dursun E, Gezen-Ak D, Eker E, Ertan T, Engin F, Hanagasi H, Gürvit H, Emre M, Yilmazer S. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 21: 268-73. PMID 19017784 DOI: 10.1177/0891988708324941  0.88
2008 Parildar-KarpuzoÄŸlu H, DoÄŸru-AbbasoÄŸlu S, Hanagasi HA, KaradaÄŸ B, Gürvit H, Emre M, Uysal M. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neuroscience Letters. 442: 287-91. PMID 18672023 DOI: 10.1016/j.neulet.2008.07.047  0.88
2008 Emre M, Mecocci P, Stender K. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 14: 193-9. PMID 18560130  0.88
2008 Gurvit H, Emre M, Tinaz S, Bilgic B, Hanagasi H, Sahin H, Gurol E, Kvaloy JT, Harmanci H. The prevalence of dementia in an urban Turkish population. American Journal of Alzheimer's Disease and Other Dementias. 23: 67-76. PMID 18276959 DOI: 10.1177/1533317507310570  0.88
2008 Oertel W, Poewe W, Wolters E, De Deyn PP, Emre M, Kirsch C, Hsu C, Tekin S, Lane R. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension. Drug Safety. 31: 79-94. PMID 18095748  0.88
2008 Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and treatment of Alzheimer's disease and other disorders associated with dementia: The EFNS guidelines | Recomendações para o diagnóstico e tratamento da doença de Alzheimer e de outras doenças associadas a demência: Orientações da EFNS Sinapse. 8: 68-93.  0.88
2007 Emre M. Clinical features, pathophysiology and treatment of dementia associated with Parkinson's disease. Handbook of Clinical Neurology. 83: 401-19. PMID 18808925 DOI: 10.1016/S0072-9752(07)83018-1  0.88
2007 Emre M. Treatment of dementia associated with Parkinson's disease. Parkinsonism & Related Disorders. 13: S457-61. PMID 18267283 DOI: 10.1016/S1353-8020(08)70049-X  0.88
2007 Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, ... ... Emre M, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2314-24. PMID 18098298 DOI: 10.1002/mds.21844  0.88
2007 Emre M, Cummings JL, Lane RM. Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences. Journal of Alzheimer's Disease : Jad. 11: 509-19. PMID 17656830  0.88
2007 Gezen-Ak D, Dursun E, Ertan T, HanaÄŸasi H, Gürvit H, Emre M, Eker E, Oztürk M, Engin F, Yilmazer S. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. The Tohoku Journal of Experimental Medicine. 212: 275-82. PMID 17592215 DOI: JST.JSTAGE/tjem/212.275  0.88
2007 Friedland RP, Emre M, Geula C. The 3rd International Symposium on Alzheimer's Disease and Related Disorders in the Middle East, Istanbul, Turkey, October 1 - 2, 2005. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 161-8. PMID 17577692 DOI: 10.1080/13506120701259606  0.88
2007 Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1689-707; quiz 1837. PMID 17542011 DOI: 10.1002/mds.21507  0.88
2007 Ehrt U, Brønnick K, De Deyn PP, Emre M, Tekin S, Lane R, Aarsland D. Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates. International Journal of Geriatric Psychiatry. 22: 980-5. PMID 17393542 DOI: 10.1002/gps.1774  0.88
2007 DoÄŸru-AbbasoÄŸlu S, Aykaç-Toker G, Hanagasi HA, Gürvit H, Emre M, Uysal M. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 28: 31-4. PMID 17385092 DOI: 10.1007/s10072-007-0744-x  0.88
2007 Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.wnl.0000256715.13907.d3  0.88
2007 Gürses C, Bilgiç B, Topçular B, Tuncer OG, Akman-Demir G, HanaÄŸasi H, Baslo B, Gürvit H, Coban O, Emre M, IdrisoÄŸlu HA. Clinical and magnetic resonance imaging findings of HIV-negative patients with neurosyphilis. Journal of Neurology. 254: 368-74. PMID 17345038 DOI: 10.1007/s00415-006-0380-z  0.88
2007 Gürses C, Kürtüncü M, Jirsch J, YeÅŸilot N, HanaÄŸasi H, Bebek N, Baykan B, Emre M, GökyiÄŸit A, Andermann F. Neurosyphilis presenting with status epilepticus. Epileptic Disorders : International Epilepsy Journal With Videotape. 9: 51-6. PMID 17307712 DOI: 10.1684/epd.2007.0058  0.88
2007 Bronnick K, Emre M, Lane R, Tekin S, Aarsland D. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 1064-8. PMID 17287236 DOI: 10.1136/jnnp.2006.108076  0.88
2007 Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: e1-26. PMID 17222085 DOI: 10.1111/j.1468-1331.2006.01605.x  0.88
2007 Aarsland D, Emre M, Lees A, Poewe W, Ballard C. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 68: 80; author reply 81. PMID 17200503 DOI: 10.1212/01.wnl.0000252956.34585.a6  0.88
2007 Hanagasi HA, Lees A, Johnson JO, Singleton A, Emre M. Smoking-responsive juvenile-onset Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 115-9. PMID 17080433 DOI: 10.1002/mds.21177  0.88
2007 Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 36-42. PMID 16820421 DOI: 10.1136/jnnp.2005.083113  0.88
2006 Lippa CF, Emre M. Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys? Neurology. 67: 1910-1. PMID 17159092 DOI: 10.1212/01.wnl.0000250234.72903.37  0.88
2006 Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1899-907. PMID 16960863 DOI: 10.1002/mds.21077  0.88
2006 Kirmizi-Alsan E, Bayraktaroglu Z, Gurvit H, Keskin YH, Emre M, Demiralp T. Comparative analysis of event-related potentials during Go/NoGo and CPT: decomposition of electrophysiological markers of response inhibition and sustained attention. Brain Research. 1104: 114-28. PMID 16824492 DOI: 10.1016/j.brainres.2006.03.010  0.88
2006 Dogru-Abbasoglu S, Inceoglu M, Parildar-Karpuzoglu H, Hanagasi HA, Karadag B, Gurvit H, Emre M, Aykac-Toker G, Uysal M. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease. Neuroscience Letters. 404: 258-61. PMID 16806697 DOI: 10.1016/j.neulet.2006.06.005  0.88
2006 Bronnick K, Ehrt U, Emre M, De Deyn PP, Wesnes K, Tekin S, Aarsland D. Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 1136-42. PMID 16801351 DOI: 10.1136/jnnp.2006.093146  0.88
2006 Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1123-30. PMID 16637023 DOI: 10.1002/mds.20897  0.88
2006 Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathologica. 111: 115-25. PMID 16468020 DOI: 10.1007/s00401-005-0003-2  0.88
2006 Sahin HA, Gurvit IH, Emre M, Hanagasi HA, Bilgic B, Harmanci H. The attitude of elderly lay people towards the symptoms of dementia. International Psychogeriatrics / Ipa. 18: 251-8. PMID 16466587 DOI: 10.1017/S1041610205002784  0.88
2006 Poewe W, Wolters E, Emre M, Onofrj M, Hsu C, Tekin S, Lane R. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 456-61. PMID 16229010 DOI: 10.1002/mds.20700  0.88
2006 Emre M. Rivastigmine in Parkinson's disease dementia: A viewpoint by Murat Emre Cns Drugs. 20: 748.  0.88
2005 Serdaroglu P, Hanagasi H, Tasli H, Emre M. Parkin expression in muscle from three patients with autosomal recessive Parkinson's disease carrying parkin mutation. Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology / Edited by the Gaetano Conte Academy For the Study of Striated Muscle Diseases. 24: 2-5. PMID 16312141  0.88
2005 Wesnes KA, McKeith I, Edgar C, Emre M, Lane R. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology. 65: 1654-6. PMID 16301500 DOI: 10.1212/01.wnl.0000184517.69816.e9  0.88
2005 Serdaroglu P, Tasli H, Hanagasi H, Emre M. Parkin expression in human skeletal muscle. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 12: 927-9. PMID 16257218 DOI: 10.1016/j.jocn.2005.04.005  0.88
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.wnl.0000187889.17253.b1  0.88
2005 Kulaksizoglu IB, Gürvit H, Polat A, Harmanci H, Cakir S, Hanagasi H, Bilgic B, Emre M. Unrecognized depression in community-dwelling elderly persons in Istanbul. International Psychogeriatrics / Ipa. 17: 303-12. PMID 16050438 DOI: 10.1017/S1041610204000845  0.88
2005 Hanagasi HA, Emre M. Treatment of behavioural symptoms and dementia in Parkinson's disease. Fundamental & Clinical Pharmacology. 19: 133-46. PMID 15810893 DOI: 10.1111/j.1472-8206.2005.00317.x  0.88
2005 Hanagasi HA, Ayribas D, Baysal K, Emre M. Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease. The International Journal of Neuroscience. 115: 479-93. PMID 15809215 DOI: 10.1080/00207450590523017  0.88
2005 Harada CN, Shega JW, Sachs GA. Rivastigmine for dementia associated with Parkinson's disease. The New England Journal of Medicine. 352: 1387; author reply 1. PMID 15800242 DOI: 10.1056/NEJM200503313521325  0.88
2005 van Gijn J, Hanagasi H, Emre M. How good at neurology are you? Questions and answers Practical Neurology. 5: 186-188. DOI: 10.1111/j.1474-7766.2005.00310.x  0.88
2005 Yokeş MB, Emre M, Harmanci H, Gürvit H, Hanaǧasi H, Şahin H, Bilgiç B, Başak AN. The apolipoprotein E (APOE) genotype in a Turkish population with Alzheimer's disease Balkan Journal of Medical Genetics. 8: 57-63.  0.88
2004 Geula C, Emre M, Friedland RP. The 2nd International Symposium on Alzheimer's disease and related disorders in the Middle East, May 1-3, 2003, Istanbul, Turkey. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 11: 276-80. PMID 15678765 DOI: 10.1080/13506120400016232  0.88
2004 Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, et al. Rivastigmine for dementia associated with Parkinson's disease. The New England Journal of Medicine. 351: 2509-18. PMID 15590953 DOI: 10.1056/NEJMoa041470  0.88
2004 Bilgic B, Baral-Kulaksizoglu I, Hanagasi H, Saylan M, Aykutlu E, Gurvit H, Emre M. Obsessive-compulsive disorder secondary to bilateral frontal damage due to a closed head injury. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 17: 118-20. PMID 15453521 DOI: 10.1097/01.wnn.0000117862.44205.ea  0.88
2004 Hanagasi HA, Bilgic B, Gurvit H, Emre M. Clozapine treatment in oromandibular dystonia. Clinical Neuropharmacology. 27: 84-6. PMID 15252269 DOI: 10.1097/00002826-200403000-00007  0.88
2004 Emre M. Dementia in Parkinson's disease: cause and treatment. Current Opinion in Neurology. 17: 399-404. PMID 15247534 DOI: 10.1097/01.wco.0000137529.30750.ab  0.88
2004 Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study. Drugs & Aging. 21: 43-53. PMID 14715043 DOI: 10.2165/00002512-200421010-00004  0.88
2003 Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Current Medical Research and Opinion. 19: 707-14. PMID 14687441 DOI: 10.1185/030079903125002450  0.88
2003 Harmanci H, Emre M, Gurvit H, Bilgic B, Hanagasi H, Gurol E, Sahin H, Tinaz S. Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, Turkey. Alzheimer Disease and Associated Disorders. 17: 139-45. PMID 14512826 DOI: 10.1097/00002093-200307000-00003  0.88
2003 Gershanik O, Emre M, Bernhard G, Sauer D. Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 963-71. PMID 14499313 DOI: 10.1016/S0278-5846(03)00156-8  0.88
2003 Emre M, Farlow M, Bullock R, Gauthier S, Grossberg G, Potkin SG. Cholinesterase inhibitors in Alzheimer's disease: A consensus view on managing treatment failure Primary Care Psychiatry. 9: 29-30. DOI: 10.1185/135525703125002739  0.88
2002 Hanagasi HA, Gurvit IH, Ermutlu N, Kaptanoglu G, Karamursel S, Idrisoglu HA, Emre M, Demiralp T. Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials. Brain Research. Cognitive Brain Research. 14: 234-44. PMID 12067696 DOI: 10.1016/S0926-6410(02)00110-6  0.88
2002 Wesnes KA, McKeith IG, Ferrara R, Emre M, Del Ser T, Spano PF, Cicin-Sain A, Anand R, Spiegel R. Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dementia and Geriatric Cognitive Disorders. 13: 183-92. PMID 11893841 DOI: 10.1159/000048651  0.88
2002 Sahin HA, Gurvit IH, Bilgiç B, Hanagasi HA, Emre M. Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease. Clinical Neuropharmacology. 25: 16-20. PMID 11852291 DOI: 10.1097/00002826-200201000-00003  0.88
2001 Gürol ME, Ertas M, Hanagasi HA, Sahin HA, Gürsoy G, Emre M. Stiff leg syndrome: case report. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 1189-93. PMID 11748762 DOI: 10.1002/mds.1224  0.48
2001 Hanagasi HA, Gürol E, Sahin HA, Emre M. Atypical neurological involvement associated with celiac disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 8: 67-9. PMID 11509083  0.48
2000 HanaÄŸasi HA, Kaptanoglu G, Sahin HA, Emre M. The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 1016-7. PMID 11009218 DOI: 10.1002/1531-8257(200009)15:5<1016::AID-MDS1042>3.0.CO;2-J  0.48
1994 Lowe DA, Emre M, Frey P, Kelly PH, Malanowski J, McAllister KH, Neijt HC, Rüdeberg C, Urwyler S, White TG. The pharmacology of SDZ EAA 494, a competitive NMDA antagonist. Neurochemistry International. 25: 583-600. PMID 7894335 DOI: 10.1016/0197-0186(94)90157-0  0.88
1993 Emre M, Heckers S, Mash DC, Geula C, Mesulam MM. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. The Journal of Comparative Neurology. 336: 117-34. PMID 8254109 DOI: 10.1002/cne.903360110  0.88
1992 Emre M, Geula C, Ransil BJ, Mesulam MM. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain. Neurobiology of Aging. 13: 553-9. PMID 1461343 DOI: 10.1016/0197-4580(92)90055-3  0.88
1986 Walser H, Sutter M, Emre M. [Automatic quantification of SEP for continuous patient monitoring]. Eeg-Emg Zeitschrift FüR Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete. 17: 11-5. PMID 3084197  0.88
1985 Emre M, Walser H, Baumgartner G. Non-convulsive status epilepticus after abrupt withdrawal of hypnotic-sedative drugs. European Archives of Psychiatry and Neurological Sciences. 235: 21-5. PMID 2864252 DOI: 10.1007/BF00380964  0.88
1984 Emre M, Landis T. Haloperidol in hemichorea-hemiballismus. Journal of Neurology. 231: 280. PMID 6520624 DOI: 10.1007/BF00313669  0.88
Show low-probability matches.